Freddo James L 4
4 · ANADYS PHARMACEUTICALS INC · Filed Dec 15, 2010
Insider Transaction Report
Form 4
Freddo James L
SVP, Drug Development and CMO
Transactions
- Award
Stock Option (Right to Buy)
2010-12-13+71,438→ 71,438 totalExercise: $1.02From: 2011-12-13Exp: 2020-12-12→ Common Stock (71,438 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest and become exercisable one year from the date of grant with the remaining shares subject to the option vesting in equal installments over the next three years such that all shares subject to the option will be fully vested and exercisable as of December 13, 2014.